These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8996050)

  • 21. An imported case of disseminated cysticercosis and taeniasis.
    Nakamura-Uchiyama F; Kobayashi K; Ohnishi K
    Intern Med; 2012; 51(3):347-8. PubMed ID: 22293822
    [No Abstract]   [Full Text] [Related]  

  • 22. Mathematical model of the life cycle of taenia-cysticercosis: transmission dynamics and chemotherapy (Part 1).
    José MV; Bobadilla JR; Sánchez-Torres NY; Laclette JP
    Theor Biol Med Model; 2018 Nov; 15(1):18. PubMed ID: 30449280
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is the course of neurocysticercosis modified by treatment with antihelminthic agents?
    Carpio A; Santillán F; León P; Flores C; Hauser WA
    Arch Intern Med; 1995 Oct; 155(18):1982-8. PubMed ID: 7575052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Failure of albendazole therapy in two common types of parenchymal neurocysticercosis.
    Garg RK; Kar AM; Jain S
    J Assoc Physicians India; 1995 Oct; 43(10):706-7. PubMed ID: 8773009
    [No Abstract]   [Full Text] [Related]  

  • 25. Medical treatment of cerebral cysticercosis.
    Estanol B
    Eur Neurol; 1997; 37(2):125-6. PubMed ID: 9058071
    [No Abstract]   [Full Text] [Related]  

  • 26. Neurocysticercosis--an unusual presentation.
    Sood AK; Yadav RK; Yadav SP; Malhotra RC; Chugh SN
    J Assoc Physicians India; 1995 Feb; 43(2):133. PubMed ID: 9282681
    [No Abstract]   [Full Text] [Related]  

  • 27. Neurocysticercosis--case report and literature review.
    Wong AS; Ho KH
    Singapore Med J; 1997 Jul; 38(7):297-9. PubMed ID: 9339097
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cysticerci-meningitis].
    Rogel-Ortiz F; Vera-Pedro M
    Gac Med Mex; 1997; 133(4):301-5. PubMed ID: 9410791
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic variability of anthelmintics: implications for the treatment of neurocysticercosis.
    Jung-Cook H
    Expert Rev Clin Pharmacol; 2012 Jan; 5(1):21-30. PubMed ID: 22142156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacokinetic optimisation of the treatment of neurocysticercosis.
    Sotelo J; Jung H
    Clin Pharmacokinet; 1998 Jun; 34(6):503-15. PubMed ID: 9646011
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Albendazole therapy in orbital cysticercosis.
    Srivastava VK; Srivastava A; Singhal KC
    Indian J Physiol Pharmacol; 1996 Jul; 40(3):265-6. PubMed ID: 8950146
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Praziquantel vs. albendazol for cysticercosis.
    Quintero-Rodriguez E
    Neurosurgery; 1988 Jul; 23(1):128. PubMed ID: 3173656
    [No Abstract]   [Full Text] [Related]  

  • 33. Isolated cardiac cysticercosis: treatment with or without steroids?
    Kalra DK; Rao A; Simms A; Pierre-Louis A
    Lancet; 2019 Jun; 393(10189):2439. PubMed ID: 31204684
    [No Abstract]   [Full Text] [Related]  

  • 34. CSF-VP shunt placement and albendazole therapy for cerebral cysticercosis.
    Zhu L; Weng X; Shi Y; Pan X; Mo L
    Chin Med J (Engl); 2002 Jun; 115(6):936-8. PubMed ID: 12136810
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased incidence of neurocysticercosis after contact with immigrants from endemic countries.
    Vogl D
    J Emerg Nurs; 1993 Apr; 19(2):80. PubMed ID: 8468892
    [No Abstract]   [Full Text] [Related]  

  • 36. Albendazole therapy for neurocysticercosis.
    Escobedo F; Penagos P; Rodriguez J; Sotelo J
    Arch Intern Med; 1987 Apr; 147(4):738-41. PubMed ID: 3827462
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neurocysticercosis.
    Salinas R; Garner P
    Arch Neurol; 1996 Mar; 53(3):213-4. PubMed ID: 8651870
    [No Abstract]   [Full Text] [Related]  

  • 38. [Albendazole treatment in cerebral cysticercosis].
    Xiao ZX; Zhao CY; Liu YP
    Zhonghua Nei Ke Za Zhi; 1986 Feb; 25(2):100-2, 127. PubMed ID: 3792122
    [No Abstract]   [Full Text] [Related]  

  • 39. [2 patients with neurocysticercosis].
    Brouwer RE; Thijssen H; van der Meer JW; Overbosch D
    Ned Tijdschr Geneeskd; 1995 Dec; 139(52):2736-8. PubMed ID: 8569888
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Albendazole therapy for neurocysticercosis: a prospective double-blind trial comparing 7 versus 14 days of treatment. Cysticercosis Working Group in Peru.
    Garcia HH; Gilman RH; Horton J; Martinez M; Herrera G; Altamirano J; Cuba JM; Rios-Saavedra N; Verastegui M; Boero J; Gonzalez AE
    Neurology; 1997 May; 48(5):1421-7. PubMed ID: 9153484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.